News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,697 Results
Type
Article (43768)
Company Profile (473)
Press Release (695444)
Multimedia
Podcasts (127)
Webinars (20)
Section
Business (209349)
Career Advice (2043)
Deals (36160)
Drug Delivery (123)
Drug Development (83988)
Employer Resources (174)
FDA (16706)
Job Trends (15194)
News (354239)
Policy (33290)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2664)
Accelerated approval (38)
Adcomms (28)
Allergies (153)
Alliances (51112)
ALS (184)
Alzheimer's disease (1744)
Antibody-drug conjugate (ADC) (344)
Approvals (16956)
Artificial intelligence (569)
Autoimmune disease (170)
Automation (44)
Bankruptcy (373)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (198)
Biotechnology (331)
Bladder cancer (168)
Brain cancer (62)
Breast cancer (665)
Cancer (5082)
Cardiovascular disease (431)
Career advice (1729)
Career pathing (39)
CAR-T (297)
CDC (50)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (37)
Clinical research (71608)
Collaboration (1855)
Company closure (4)
Compensation (1205)
Complete response letters (68)
COVID-19 (2777)
CRISPR (103)
C-suite (925)
Cystic fibrosis (152)
Data (6509)
Decentralized trials (2)
Denatured (41)
Depression (147)
Diabetes (515)
Diagnostics (6799)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (279)
Drug pricing (199)
Drug shortages (29)
Duchenne muscular dystrophy (254)
Earnings (91717)
Editorial (62)
Employer branding (21)
Employer resources (153)
Events (121418)
Executive appointments (1026)
FDA (19947)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1574)
Gene editing (222)
Generative AI (46)
Gene therapy (666)
GLP-1 (1026)
Government (4772)
Grass and pollen (6)
Guidances (386)
Healthcare (19224)
HIV (70)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (281)
Immuno-oncology (70)
Indications (126)
Infectious disease (3067)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (263)
Interviews (316)
IPO (16936)
IRA (53)
Job creations (3715)
Job search strategy (1441)
JPM (67)
Kidney cancer (18)
Labor market (87)
Layoffs (582)
Leadership (35)
Legal (8029)
Liver cancer (94)
Longevity (17)
Lung cancer (686)
Lymphoma (389)
Machine learning (44)
Management (59)
Manufacturing (843)
MASH (173)
Medical device (13946)
Medtech (14006)
Mergers & acquisitions (20319)
Metabolic disorders (1349)
mRNA (184)
Multiple sclerosis (171)
NASH (19)
Neurodegenerative disease (354)
Neuropsychiatric disorders (98)
Neuroscience (3082)
Neurotech (1)
NextGen: Class of 2026 (6771)
Non-profit (4587)
Now hiring (69)
Obesity (647)
Opinion (291)
Ovarian cancer (170)
Pain (212)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (34)
Patents (521)
Patient recruitment (533)
Peanut (60)
People (60424)
Pharmaceutical (85)
Pharmacy benefit managers (31)
Phase 1 (22524)
Phase 2 (31570)
Phase 3 (23336)
Pipeline (5811)
Policy (309)
Postmarket research (2602)
Preclinical (9626)
Press Release (67)
Prostate cancer (259)
Psychedelics (56)
Radiopharmaceuticals (309)
Rare diseases (939)
Real estate (6066)
Recruiting (71)
Regulatory (25149)
Reports (53)
Research institute (2493)
Resumes & cover letters (355)
Rett syndrome (28)
RNA editing (21)
RSV (81)
Schizophrenia (158)
Series A (265)
Series B (204)
Service/supplier (11)
Sickle cell disease (109)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3808)
State (2)
Stomach cancer (19)
Supply chain (108)
Tariffs (85)
The Weekly (84)
Vaccines (1048)
Venture capital (96)
Weight loss (420)
Women's health (100)
Worklife (20)
Date
Today (240)
Last 7 days (925)
Last 30 days (2908)
Last 365 days (30871)
2026 (4896)
2025 (31063)
2024 (36297)
2023 (41014)
2022 (52279)
2021 (56767)
2020 (54923)
2019 (47421)
2018 (35699)
2017 (33023)
2016 (32347)
2015 (38396)
2014 (32186)
2013 (27111)
2012 (29221)
2011 (29864)
2010 (27992)
Location
Africa (754)
Alabama (92)
Alaska (7)
Arizona (324)
Arkansas (15)
Asia (40750)
Australia (6773)
California (11819)
Canada (3373)
China (1161)
Colorado (496)
Connecticut (510)
Delaware (344)
Europe (89447)
Florida (1755)
Georgia (372)
Hawaii (3)
Idaho (61)
Illinois (912)
India (71)
Indiana (540)
Iowa (24)
Japan (451)
Kansas (131)
Kentucky (43)
Louisiana (28)
Maine (72)
Maryland (1436)
Massachusetts (8568)
Michigan (337)
Minnesota (646)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (29)
Nevada (125)
New Hampshire (85)
New Jersey (3142)
New Mexico (31)
New York (3086)
North Carolina (1567)
North Dakota (9)
Northern California (5786)
Ohio (351)
Oklahoma (21)
Oregon (45)
Pennsylvania (2367)
Puerto Rico (24)
Rhode Island (50)
South America (1122)
South Carolina (68)
South Dakota (1)
Southern California (4587)
Tennessee (180)
Texas (1812)
United States (41966)
Utah (355)
Vermont (1)
Virginia (278)
Washington D.C. (82)
Washington State (972)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
739,697 Results for "seismic therapeutic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seismic Therapeutic to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
1 min read
Press Releases
Seismic Therapeutic Announces Updated Presentation Time at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Seismic Therapeutic to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026
December 16, 2025
·
1 min read
Press Releases
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
February 11, 2026
·
7 min read
Genetown
Seismic Therapeutic to Participate in Upcoming June Investor Conferences
Seismic Therapeutic, Inc today announced that company management will participate in the following June investor conferences.
May 29, 2024
·
1 min read
Business
Seismic Therapeutic Appoints Brendan St. Amant as General Counsel
Seismic Therapeutic, Inc today announced the appointment of Brendan St. Amant as General Counsel and a member of the company’s leadership team.
June 25, 2024
·
2 min read
Genetown
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in June 2024
Seismic Therapeutic, Inc today announced that the company will participate in three upcoming scientific conferences.
June 4, 2024
·
3 min read
Press Releases
Seismic Therapeutic Appoints Sophie Jones, M.D., as Chief Financial Officer
June 2, 2025
·
2 min read
Opinion
Addressing the Regulatory Reality of Replacing
In Vivo
Models in Drug Development
The FDA’s announcement that it will phase out
in vivo
testing requirements for monoclonal antibodies marks a seismic shift. Here’s how industry can adapt.
January 5, 2026
·
6 min read
·
Xiaoxia Li
Genetown
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in April and May 2024
Seismic Therapeutic, Inc today announced that the company will participate in four upcoming scientific conferences, presenting the company’s emerging pipeline of novel therapeutics to treat rare and prevalent autoimmune diseases.
April 9, 2024
·
4 min read
1 of 73,970
Next
